Background-Gene-nutrient interactions affecting high-density lipoprotein cholesterol (HDL-C) concentrations may contribute to the interindividual variability of the cardiovascular disease risk associated with dietary fat intake. Hepatic lipase (HL) is a key determinant of HDL metabolism. Four polymorphisms in linkage disequilibrium have been identified in the HL gene (LIPC), defining what is known as the Ϫ514T allele. This allele has been associated with decreased HL activity and increased HDL-C concentrations. However, the effect is variable among populations. Methods and Results-We have examined interaction effects between the Ϫ514(C/T) LIPC polymorphism, dietary fat, and HDL-related measures in 1020 men and 1110 women participating in the Framingham Study. We found a consistent and highly significant gene-nutrient interaction showing a strong dose-response effect. Thus, the T allele was associated with significantly greater HDL-C concentrations only in subjects consuming Ͻ30% of energy from fat (PϽ0.001). When total fat intake was Ն30% of energy, mean HDL-C concentrations were lowest among those with the TT genotype, and no differences were observed between CC and CT individuals. We found similar gene-nutrient interactions when the outcome variables were HDL 2 -C (PϽ0.001), large HDL subfraction (PϽ0.001), or HDL size (Pϭ0.001). These interactions were seen for saturated and monounsaturated fat intakes (highly correlated with animal fat in this population), but not for polyunsaturated fat. Conclusions-Dietary fat intake modifies the effect of the Ϫ514(C/T) polymorphism on HDL-C concentrations and subclasses. Specifically, in the Framingham Study, TT subjects may have an impaired adaptation to higher animal fat diets that could result in higher cardiovascular risk.
L ow plasma high-density lipoprotein cholesterol (HDL-C) concentrations are a major risk factor for coronary artery disease (CAD). In general, HDL-C increases with physical activity, alcohol consumption, and diets high in saturated fatty acids (SFA). However, it is still important to reduce SFA intake because LDL-C increases even more. Conversely, smoking and replacement of dietary fat with carbohydrates decreases HDL-C 1 . Well-controlled experimental studies have demonstrated heterogeneity of the plasma lipid response to dietary fat and suggested a genetic component. [2] [3] [4] Thus, gene-nutrient interactions affecting HDL metabolism may contribute to the substantial interindividual variability on the effects of low-fat diets on plasma lipids. 2, 4 From a public health perspective, and considering that diet is the cornerstone of the prevention and treatment of CAD, in addition to the low-density lipoprotein cholesterol (LDL-C)-lowering factors, it is highly relevant to understand those involved on the dietary regulation of HDL metabolism. 1 Hepatic lipase (HL) is a lipolytic enzyme that hydrolyzes triglycerides (TG) and phospholipids on plasma lipoproteins, 5 and it has been suggested to be a novel CAD risk factor. 6 HL also plays a role as a ligand mediating the binding and uptake of lipoproteins via proteoglycans and/or receptor pathways. 7 Thus, both lipolytic and nonlipolytic functions of HL are important for HDL metabolism and ultimately to its association with CAD risk. 8 Overall, overexpression of HL de-creases HDL-C concentration, whereas HL deficiency increases it. 9 A common Ϫ514 C to T substitution has been described in the promoter region of the HL gene (LIPC). The T allele is associated with decreased plasma HL activity, increased HDL-C concentrations, 10 -12 and increased large HDL subfractions. 13 Although it is known that diet is an important factor influencing HDL-C concentrations and HDL subclasses, previous studies did not assess potential gene-diet interaction between the Ϫ541C/T polymorphism and dietary fat. Thus, the present study was designed to investigate how dietary fat intake, focusing on specific fatty acids and fat sources, interacts with the LIPC polymorphism to determine both HDL-C concentrations and particle size in subjects participating in the Framingham Study.
Methods

Subjects and Study Design
The design and methods of the Framingham Offspring Study (FOS) have been presented elsewhere. 14 Starting in 1971, 5124 predominantly white subjects were enrolled. Blood samples for DNA were collected between 1987 and 1991. Lipids, genotypes, CHD risk factors, and dietary intake were determined for participants (nϭ3515) who attended the fifth examination visit, conducted between 1992 and 1995. HL genotyping was performed as previously described. 13 Subjects taking lipid-lowering medications (nϭ166) were excluded from this analysis. The present study describes the results of analysis performed in 1020 men and 1110 women (aged 28 to 79 years) who had complete data for all variables examined (the most limiting variables being the data for HDL subfractions and LIPC genotypes). The sample studied did not differ from total population for the variables of interest.
Plasma Lipid, Lipoprotein, and Apolipoprotein Measurements
Sample collections and biochemical techniques were as described. 15 HDL subclass distributions were determined by proton nuclear magnetic resonance (NMR) spectroscopy. 16, 17 HDL subclass categories were grouped as large HDL (8.8 to 13.0 nm), intermediate HDL (7.8 to 8.7 nm), and small HDL (7.3 to 7.7 nm). 13 
Dietary Assessment
Dietary intake was estimated with the semiquantitative Willett food-frequency questionnaire (136 food items). 18, 19 Alcohol consumption was calculated and subjects were also classified as either nondrinkers or drinkers. 19 
Statistical Analyses
Student's t test and 2 tests were applied to test differences in means and in percentages. To evaluate the relationship between the LIPC genotypes and dependent variables, we used analysis of covariance. To test the null hypothesis of no interaction between the LIPC genotypes and dietary fat, interaction terms were included in the models. First, with the use of Proc Mixed in SAS (v.8), we obtained crude results which accounted only for the familial relationships among the members of the study (mostly siblings and cousins). 16 Second, we obtained adjusted results after accounting for familial , smoking, alcohol, estrogens in women, ␤-blockers, and energy). Men and women were analyzed together because no heterogeneity of allelic effect by sex was detected. To depict the interaction effect between LIPC genotype and fat in determining HDL-C metabolism, predicted values for each dependent variable from the corresponding regression model were computed. As measure of the goodness-of-fit of the models, the square of the correlation coefficient was calculated. In addition, means in fat categories were added to figures as a second measure. All reported probability values were two-sided. Table 1 shows anthropometric, biochemical, dietary, and genetic data. The prevalence of subjects with diabetes was 5.5%. Genotype frequencies did not deviate from the HardyWeinberg equilibrium. HDL-C concentrations were higher and HDL size increased in carriers of the T allele (Table 2) , as previously described in this population. 13 No significant differences in LDL-C and TG, dietary fat, or alcohol consumption across the LIPC genotypes were detected.
Results
To test if dietary fat modifies the effect of the LIPC polymorphism, we first examined total fat intake categories according to the population mean (30% of energy). We found a strong interaction between the LIPC polymorphism and total fat consumption on HDL-C concentrations (P for interaction Ͻ0.001; Figure 1 ). The T allele was associated with an increase in HDL-C (8.7% in CT and 15.9% in TT; PϽ0.001) in subjects consuming Ͻ30% of energy from fat. However, mean HDL-C concentrations were lowest among those with the TT genotype and total fat intakes Ն30%, (Ϫ9.5%; PϽ0.05), and no differences were observed between CC and CT individuals. We found similar gene-nutrient interactions for HDL 2 -C (PϽ0.001), large HDL subfraction (PϽ0.001), and HDL size (Pϭ0.001).
Furthermore, we examined the effect of total fat and specific fatty acids (FA) as continuous variables. Table 3 displays regression coefficients for main effects and for interaction terms between total fat or specific FA and LIPC genotypes in determining HDL-C concentrations. To increase interpretability, two separate regression models (fat-centered and noncentered) were fitted for each type of fat. We observed significant interaction (PϽ0.001) between total fat and LIPC genotype. Partial regression coefficients for the interaction effect in CT and TT individuals were both statistically significant as compared with CC individuals. We also found statistically significant interactions with SFA (Pϭ0.002) and monounsatu- The dependent variable was HDL-C (mmol/L). B indicates regression coefficient; SE, standard error. Slopes for the CC, CT, and TT genotypes for each type of fat can be easily obtained: the fat intake term is the CC slope (0.009, for total fat); the CTϫfat intake termϩthe CC slope is the CT slope (0.003, for total fat); and the TTϫfat intake termϩthe CC slope is the TT slope (Ϫ0.009 for total fat).
*Two separate regression models (one fat-centered and one noncentered) were fitted for each type of fat (as continuous). Models were additionally adjusted for familial relationships, sex, age, BMI, smoking, alcohol intake, estrogen therapy in women, use of ␤-blockers, and energy intake. The centered and noncentered approaches yield identical regression model statistics and tests for interaction effects.
†In the fat-centered model, the mean of each fat was subtracted from the corresponding original fat variables, so the main effect terms are interpretable as the HDL-C concentrations at the corresponding mean values for each fat. ‡In the noncentered model, variables were not transformed. §Regression coefficients and significance for these terms were the same in the fat-centered and noncentered models.
rated fatty acid (MUFA) (Pϭ0.001). However, there was no significant interaction (Pϭ0.36) with polyunsaturated fatty acid (PUFA). According to the noncentered regression model in Table 3 , and to depict the interaction effect, Figure 2 shows the modification of the effect of the LIPC polymorphism on HDL-C (A) and HDL size (B) by the amount of total fat consumed. Differences in slope of the regression lines indicate that the effect of total fat on HDL-C concentrations or size depends on the LIPC genotype. Low fat intake was associated with higher HDL-C concentrations in TT individuals. However, in these subjects, HDL-C decreased as total fat intake increased. The opposite effect was found in CC subjects. Moreover, in CC subjects, HDL particle size was associated with higher fat intake, whereas increased fat intake decreased HDL particle size in CT and TT individuals. These effects on HDL metabolism were consistently found on different HDL subfractions even after controlling for potential confounders ( Table 4) . As intakes of specific types of fat correlate one with another, we examined this correlation by source of fat (Table  5 ). MUFA and SFA were highly correlated with animal fat as a result of shared sources of SFA and MUFA in this American population. Consequently, we performed further analysis considering the source of fat (animal or vegetable). Multivariate regression models were fitted for animal and vegetable fat. Models were additionally adjusted for carbohydrates and for vegetable or animal fat. For animal fat, the statistical significance of the interaction terms with the LIPC polymorphism were PϽ0.001, Pϭ0.003, PϽ0.001, and Pϭ0.048 in determining HDL-C, HDL particle size, large-HDL subfraction, and intermediateϩsmall HDL subfractions, respectively. The effect of animal fat on these variables was in the same direction as that for total fat. Adjusted slopes (in mmol/L per % of fat) in estimating HDL-C from animal fat were 0.014, PϽ0.001, in the CC genotype; 0.008, Pϭ0.051 for difference from the CT genotype; and Ϫ0.017, PϽ0.001 for difference from the TT genotype. Figure 3 shows the interaction effect of the LIPC polymorphisms and animal fat on large-HDL subfractions (3A) and on intermediateϩsmall HDL subfractions (3B). However, we did not find statistically significant interactions between vegetable fat and the LIPC polymorphism in determining HDL-C (Pϭ0.400), HDL particle size (Pϭ0.415), large-HDL (Pϭ0.332), and intermediateϩsmall HDL subfractions (Pϭ0.738). Adjusted slopes (in mmol/L per % of fat) in estimating HDL-C from vegetable fat were 0.001, Pϭ0.611, in the CC genotype; Ϫ0.004, Pϭ0.161 for difference from the CT genotype; and Ϫ0.006, Pϭ0.611 for difference from the TT genotype, all close to 0.
To gain further insights into the mechanisms by which total fat modulates the effect of the LIPC polymorphism on HDL metabolism, this interaction was analyzed for plasma LDL-C, TG, and fasting glucose concentrations. The statistical significance of the interaction terms between the LIPC polymorphism and total fat intake after control for confounders were Pϭ0.944, Pϭ0.154, and Pϭ0.054 in determining LDL-C, TG, and glucose, respectively. No modification of the effect by fat was seen for LDL-C, although TG and glucose were affected. TT subjects showed higher concentrations of glucose (5. mmol/L), when consuming more than and less than 30% fat, respectively. However, when the association of diabetes with the LIPC polymorphism was examined, we found no differences in the percentage of diabetic subjects by genotype (5.67%, 5.44%, and 5.48% for CC, CT, and TT individuals, respectively, Pϭ0.978). Finally, additional control for diabetes as a potential confounder was considered. The adjustment for diabetes had no effect at all on the previously obtained results.
Discussion
In this population-based study from a well-characterized US cohort, we found a highly significant gene-nutrient interaction. The association of the Ϫ514C/T polymorphism with measures of HDL-C metabolism depended on the amount and type of fat consumed. Our results confirm previous findings in this 13 and in other populations showing that the T allele is associated with higher HDL-C and HDL 2 -C concentrations, as well as large particle size 10, 12, 20, 21 when no stratification by fat intake was considered. However, we found that the T allele was only associated with higher HDL-C and size in subjects consuming Ͻ30% of energy from fat. This gene-diet interaction could help explain some of the reports showing no association between the T allele and HDL-C. [22] [23] [24] Several studies have reported that the T allele, which is in complete linkage disequilibrium with 3 other promotor polymorphisms (Ϫ250 G/A, Ϫ710 T/G, and Ϫ763 A/C), is associated with markedly decreased plasma HL activity, 5, 25 which in turn may confer increased HDL-C concentrations and size. Moreover, its functionality has been demonstrated. 26 HL is responsible for the lipolysis of both VLDL remnant particles and large LDL, as well as the conversion of HDL 2 to HDL 3 particles. In some studies, 3, 27 but not in others, 21, 22 an increase in HL activity has been related to an increase in small LDL particles. In our study, the increased HDL particle size related to the T allele was not significantly associated with large LDL particles, 13 suggesting that other genetic or environmental factors may modulate this association. Moreover, there is contradictory experimental and epidemiological data about the association between HL activity and CAD. 5 Dugi et al 6 reported that low HL activity is a risk factor for CAD, consistent with the results of Jansen et al, 25 which show that patients with genetic HL deficiency develop premature CAD, and with the observation that mice overexpressing HL have reduced atherosclerosis despite decreases in HDL-C. 5, 9 These associations are paradoxical because it has been described that low HL activity leads to higher HDL-C and a more antiatherogenic lipid profile. This apparent contradiction may be resolved by other consequences of HL activity. Thus, an antiatherogenic role for the HL has also been described because HL activity correlates with postprandial lipid concentrations and the HL deficiency is associated with impaired clearance of lipoprotein remnants. 8 We have limited knowledge about the genetic regulation of HL in humans. It has been described that even among Ϫ514T homozygotes, HL activity is quite variable, indicating that other factors modulate the allele effects on LIPC expression. 27 HL activity is higher in men, in smokers, and in those with diabetes, and it increases with intra-abdominal fat and BMI. 22, 28 However, information about the effects of dietary fat on HL activity is limited and contradictory. Campos et al 29 described increases in lipoprotein lipase (LPL) and HL activities in subjects consuming a high-fat (46% of energy) compared with a low-fat (24% of energy) diet. Conversely, Kasim et al 30 observed that LPL, but not HL activity, decreased during dietary fat restriction in women. Dreon et al 3 reported that an increase in dietary SFA was associated with decreased HL activity, suggesting that diet-induced changes in HL may contribute to the regulation of large LDL particles. On the basis of our results, we hypothesize that the effect of dietary fat on HL activity depends on the Ϫ514C/T polymorphism. An important finding of the present study is the consistency of this interaction in determining several outcome variables related to HDL metabolism and to HL activity after controlling for possible confounders. Moreover, this strong interaction showed a clear dose-response effect. We found a gene-dosage effect when total fat was considered both as categorical and as a continuous variable. Increases in †The multivariate models included familial relationships, sex, age, BMI, smoking, alcohol intake, estrogen therapy in women, use of ␤-blockers, energy intake, HL genotype, and the specific fat intake. ‡Multivariate models were additionally adjusted for carbohydrates (% of energy) and for SFA, MUFA, or PUFA (as continuous) in order to mutually adjust intakes of specific types of fatty acids for each other.
total fat were associated with increases in HDL-C concentrations in CC and CT individuals but with a different slope. In contrast, a similar increase in total fat intake in TT individuals was associated with a decrease in HDL-C. These results are in agreement with the general observation that HDL-C concentrations increase with diets high in fat 2, 30 because of the high prevalence of CC and CT individuals in the general population. Moreover, we identify a specific subgroup (TT subjects) whose HDL-C may respond differently to changes in dietary fat intake than the majority of the population (CC subjects).
Less information is available about changes in HDL subclasses, which are associated with the amount of fat consumed. We found that higher total fat intake was associated with an increase in HDL particle size only in CC subjects, whereas the opposite was true for CT and TT individuals. Berglund et al 2 investigated the effect of reduction of total and SFA on HDL concentration and size in a randomized study, showing that larger-sized HDL subpopulations decreased with the reduction of dietary fat. Considering that CC subjects make up the majority of white populations, their global results are in agreement with our observation in CC individuals.
When specific types of FA were analyzed, we found statistically significant interaction terms with SFA and MUFA, but not for PUFA, consistent with the concept that SFA and MUFA intake are associated with higher HDL-C. 1, 4 Consistent with the observations that MUFA and SFA were highly correlated as a result of shared sources of these fats (ie, meat and dairy products) in our population, we only found statistically significant interactions for animal fat. The effect of this source of fat paralleled that previously described for total fat, and the effect of animal fat intake on larger-and smaller-sized HDL subpopulations depending on the LIPC genotype was more significant. Thus, in CC subjects, largesized HDL decreased with the reduction in dietary animal fat, and a corresponding relative increase was seen for the smaller-sized HDL. The opposite was true for CT and TT. However, we cannot conclude that these results are exclusively a result of the fat component of the diet as other constituents of animal foods might play a role, particularly those that are fat soluble. Another issue that needs further consideration and that has not been addressed in the present article relates to the role of trans-fatty acids in the reported interactions.
The design of our study cannot address the mechanism by which dietary fat interacts with the Ϫ514C/T polymorphism. It has been reported that high glucose increases LIPC mRNA levels, 31 providing a molecular foundation for a role of hyperglycemia in altered HDL metabolism. Previous studies have reported that insulin upregulates the activity of HL via insulin-responsive elements in the LIPC promoter, suggesting that variants in this promoter may affect the ability of insulin to stimulate HL activity. 5 Jansen et al 25 have reported an association between the LIPC promoter variants and insulin resistance, suggesting some potential mechanisms compatible with our results.
In summary, this highly significant gene-nutrient interaction may help to explain conflicting results with regard to HL activity, the antiatherogenic lipid profile and CAD risk, as well as the intra-individual differences in the plasma lipid response to the dietary fat. Most interesting is the fact that the observed effects are exclusively found for animal fat but not so for vegetable fat. This point requires further investigation with well-controlled experimental studies. 
